High susceptibility to Zymbal gland and intestinal carcinogenesis in diabetic Otsuka Long-Evans Tokushima Fatty Rats

Journal of Toxicologic Pathology

Volumn 24, Issue 4, 2011, Pages 187-193

  Hafez, Ezar ^a   Takahashi, Tetsuyuki ^a   Ogawa, Hirohisa ^a   Sato, Makoto ^a   Nakai, Tokiko ^a   Takasu, Chie ^a   Uehara, Hisanori ^a   Izumi, Keisuke ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Carcinogenesis; Colon; Hyperlipidemia; OLETF rat; Zymbal gland

Indexed keywords

FATTY ACID; INSULIN; SOMATOMEDIN C; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CECUM CARCINOMA; COLON ADENOCARCINOMA; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; INTESTINE CANCER; LIVER CELL CULTURE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; PROTEIN EXPRESSION; RADIATION DOSE DISTRIBUTION; RAT; SEBACEOUS GLAND TUMOR; SMALL INTESTINE CARCINOMA; STRAIN DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; TUMOR VOLUME; WHOLE BODY RADIATION; ZYMBAL GLAND TUMOR;

EID: 84862934093     PISSN: 09149198     EISSN: None     Source Type: Journal    
DOI: 10.1293/tox.24.187     Document Type: Article

References (23)

1. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, and Tsugane S. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med. 166: 1871-1877. 2006. [Medline] [Cross-Ref].
2. Limburg PJ, Vierkant RA, Fredericksen ZS, Leibson CL, Rizza RA, Gupta AK, Ahlquist DA, Melton LJ 3rd, Sellers TA, and Cerhan JR. Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study. Am J Gastroenterol. 101: 1872-1879. 2006. [Medline] [CrossRef].
3. Renehan AG, Tyson M, Egger M, Heller RF, and Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 371: 569-578. 2008. [Medline] [CrossRef].
4. van Kruijsdijk RC, van der Wall E, and Visseren FL. Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev. 18: 2569-2578. 2009. [Medline] [CrossRef].
5. Hursting SD, Smith SM, Lashinger LM, Harvey AE, and Perkins SN. Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research. Carcinogenesis. 31: 83-89. 2010. [Medline] [CrossRef].
6. Vinikoor LC, Long MD, Keku TO, Martin CF, Galanko JA, and Sandler RS. The association between diabetes, insulin use, and colorectal cancer among Whites and African Americans. Cancer Epidemiol Biomarkers Prev. 18: 1239-1242. 2009. [Medline] [CrossRef].
7. Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, and Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes. 41: 1422-1428. 1992. [Medline] [CrossRef].
8. Funakoshi A, Miyasaka K, Shinozaki H, Masuda M, Kawanami T, Takata Y, and Kono A. An animal model of congenital defect of gene expression of cholecystokinin (CCK) A receptor. Biochem Biophys Res Commun. 210: 787-796. 1995. [Medline] [CrossRef].
9. Takiguchi S, Takata Y, Funakoshi A, Miyasaka K, Kataoka K, Fujimura Y, Goto T, and Kono A. Disrupted cholecystokinin type-A receptor (CCKAR) gene in OLETF rats. Gene. 197: 169-175. 1997. [Medline] [CrossRef].
10. Sakano K, Takahashi M, Mutoh M, Niho N, Komiya M, Sato H, Tanaka T, Sugimura T, and Wakabayashi K. Enhanced thyroid carcinogenicity of N-nitrosobis(2-oxopropyl)amine in Otsuka Long-Evans Tokushima Fatty rats, a model of type II diabetes mellitus. Carcinogenesis. 28: 2193-2198. 2007. [Medline] [CrossRef].
11. Chua SC Jr, Chung WK, Wu-Peng XS, Zhang Y, Liu SM, Tartaglia L, and Leibel RL. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science. 271: 994-996. 1996. [Medline] [CrossRef].
12. Phillips MS, Liu Q, Hammond HA, Dugan V, Hey PJ, Caskey CJ, and Hess JF. Leptin receptor missense mutation in the fatty Zucker rat. Nat Genet. 13: 18-19. 1996. [Medline] [CrossRef].
13. Weber RV, Stein DE, Scholes J, and Kral JG. Obesity potentiates AOM-induced colon cancer. Dig Dis Sci. 45: 890-895. 2000. [Medline] [CrossRef].
14. Jain SS, and Bird RP. Elevated expression of tumor necrosis factor-alpha signaling molecules in colonic tumors of Zucker obese (fa/fa) rats. Int J Cancer. 127: 2042-2050. 2010. [Medline] [CrossRef].
15. Moran TH, and Bi S. Hyperphagia and obesity in OLETF rats lacking CCK-1 receptors. Philos Trans R Soc Lond B Biol Sci. 361: 1211-1218. 2006. [Medline] [CrossRef].
16. Niho N, Takahashi M, Kitamura T, Shoji Y, Itoh M, Noda T, Sugimura T, and Wakabayashi K. Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands. Cancer Res. 63: 6090-6095. 2003. [Medline].
17. Mutoh M, Niho N, Komiya M, Takahashi M, Ohtsubo R, Nakatogawa K, Ueda K, Sugimura T, and Wakabayashi K. Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice. Carcinogenesis. 29: 824-829. 2008. [Medline] [CrossRef].
18. Tran TT, Medline A, and Bruce WR. Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarkers Prev. 5: 1013-1015. 1996. [Medline].
19. Lijinsky W, Saavedra JE, and Reuber MD. Organ-specific carcinogenesis in rats by methyl and ethylazoxyalkanes. Cancer Res. 45: 76-79. 1985. [Medline].
20. Lijinsky W, Thomas BJ, and Kovatch RM. Local and systemic carcinogenic effects of alkylating carcinogens in rats treated by intravesicular administration. Jpn J Cancer Res. 82: 980-986. 1991. [Medline].
21. Yoshida MC, Masuda R, Sasaki M, Takeichi N, Kobayashi H, Dempo K, and Mori M. New mutation causing hereditary hepatitis in the laboratory rat. J Hered. 78: 361-365. 1987. [Medline].
22. Ohgaki H, Hasegawa H, Kato T, Suenaga M, Ubukata M, Sato S, Takayama S, and Sugimura T. Carcinogenicity in mice and rats of heterocyclic amines in cooked foods. Environ Health Perspect. 67: 129-134. 1986. [Medline] [CrossRef].
23. Ponti G, and Ponz de Leon M. Muir-Torre syndrome. Lancet Oncol. 6: 980-987. 2005. [Medline] [CrossRef].